Estrella Immunopharma (formerly known as TradeUP Acquisition) is a company that develops transformative cancer medicines. The company focuses on T-cell therapies for patient care beyond hematological malignancies combining CD19-Redirected ARTEMIS T Cells with cancer-labeling technology.